ATRY — Atrys Health SA Income Statement
0.000.00%
- €213.30m
- €453.50m
- €141.01m
Annual income statement for Atrys Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 121 | 158 | 202 | 213 | 141 |
| Cost of Revenue | |||||
| Gross Profit | 101 | 126 | 142 | 145 | 61.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 136 | 172 | 202 | 223 | 183 |
| Operating Profit | -15.4 | -13.4 | -0.887 | -10.6 | -41.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24.9 | -26.8 | -33.7 | -33.5 | -56.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -23.2 | -26 | -30.8 | -31.8 | -55.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -23.3 | -23.1 | -45.6 | -31.8 | -100 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -23.3 | -23.1 | -45.6 | -31.8 | -100 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.456 | -0.349 | -0.404 | -0.26 | -0.449 |